Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for E2F7_E2F1
Z-value: 5.50
Motif logo
Transcription factors associated with E2F7_E2F1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
E2F7
|
ENSG00000165891.11 | E2F transcription factor 7 |
|
E2F1
|
ENSG00000101412.9 | E2F transcription factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2F1 | hg19_v2_chr20_-_32274179_32274213 | 0.82 | 1.2e-05 | Click! |
| E2F7 | hg19_v2_chr12_-_77459306_77459365 | 0.66 | 1.7e-03 | Click! |
Activity profile of E2F7_E2F1 motif
Sorted Z-values of E2F7_E2F1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of E2F7_E2F1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.1 | 35.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 6.6 | 19.7 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 6.0 | 18.0 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 5.8 | 17.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 5.3 | 15.8 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 4.9 | 38.9 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 4.5 | 4.5 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 4.1 | 12.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 4.0 | 4.0 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 3.6 | 47.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 3.6 | 14.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 3.4 | 13.7 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 3.2 | 9.7 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 3.0 | 20.9 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 3.0 | 8.9 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 3.0 | 3.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 2.9 | 8.6 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 2.5 | 7.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 2.5 | 15.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 2.4 | 9.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 2.4 | 7.2 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 2.2 | 6.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 2.2 | 13.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.2 | 13.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 2.2 | 25.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.1 | 6.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 2.1 | 8.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 2.1 | 8.4 | GO:0061743 | motor learning(GO:0061743) |
| 1.9 | 7.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 1.9 | 5.7 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.9 | 18.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.8 | 9.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.8 | 3.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.7 | 12.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 1.7 | 6.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.7 | 10.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 1.7 | 10.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.7 | 3.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 1.6 | 8.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 1.6 | 4.7 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
| 1.5 | 6.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 1.5 | 6.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.5 | 10.6 | GO:0060356 | leucine import(GO:0060356) |
| 1.5 | 4.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 1.5 | 8.8 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 1.5 | 1.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.5 | 4.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 1.5 | 5.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.4 | 7.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.4 | 4.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 1.4 | 2.8 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.4 | 21.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 1.3 | 4.0 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 1.3 | 4.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.3 | 14.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.3 | 7.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.3 | 8.9 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 1.2 | 4.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 1.2 | 3.7 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 1.2 | 48.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.2 | 6.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.2 | 15.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.2 | 5.8 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.2 | 10.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.1 | 8.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 1.1 | 4.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.1 | 6.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 1.1 | 5.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.1 | 3.4 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 1.1 | 3.3 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.1 | 14.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.1 | 46.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 1.1 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 1.1 | 6.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 1.0 | 16.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 1.0 | 3.1 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.0 | 3.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.0 | 32.6 | GO:0000732 | strand displacement(GO:0000732) |
| 1.0 | 10.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 1.0 | 3.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 1.0 | 3.9 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 1.0 | 2.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.0 | 3.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 1.0 | 4.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.9 | 27.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.9 | 3.8 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 0.9 | 9.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.9 | 2.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.9 | 0.9 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.9 | 2.6 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.9 | 0.9 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.9 | 3.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.9 | 5.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.8 | 3.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.8 | 11.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.8 | 8.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.8 | 3.3 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.8 | 2.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.8 | 4.1 | GO:1903971 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.8 | 3.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.8 | 12.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.8 | 4.8 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.8 | 6.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.8 | 2.4 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.8 | 3.9 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.8 | 6.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.8 | 1.6 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.8 | 3.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.7 | 0.7 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.7 | 2.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.7 | 6.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.7 | 2.9 | GO:0032053 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
| 0.7 | 2.9 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.7 | 2.8 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.7 | 9.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.7 | 6.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.7 | 2.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.7 | 3.4 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.7 | 5.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.7 | 2.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.7 | 2.0 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.7 | 1.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.7 | 6.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 | 2.0 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.6 | 4.5 | GO:0033504 | floor plate development(GO:0033504) |
| 0.6 | 1.9 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.6 | 1.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.6 | 42.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.6 | 3.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.6 | 1.3 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.6 | 4.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.6 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 | 3.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 | 5.6 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.6 | 0.6 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.6 | 1.8 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
| 0.6 | 2.4 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.6 | 4.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.6 | 3.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.6 | 1.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.6 | 2.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 | 2.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 | 5.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.6 | 2.3 | GO:0060032 | notochord regression(GO:0060032) |
| 0.6 | 4.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.6 | 6.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.6 | 0.6 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 | 1.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.6 | 4.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.6 | 12.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.6 | 2.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 | 2.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.5 | 9.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.5 | 3.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 5.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 3.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) L-kynurenine metabolic process(GO:0097052) |
| 0.5 | 2.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.5 | 1.6 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.5 | 2.1 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.5 | 1.5 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.5 | 2.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.5 | 2.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.5 | 4.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.5 | 2.5 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 3.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 | 2.4 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 1.4 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.5 | 2.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.5 | 5.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.5 | 1.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.5 | 5.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.4 | 2.7 | GO:0007135 | meiosis II(GO:0007135) |
| 0.4 | 2.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.4 | 6.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.4 | 2.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.4 | 2.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 4.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.4 | 8.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.4 | 4.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 | 2.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.4 | 1.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 | 1.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.4 | 1.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.4 | 9.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.4 | 1.7 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 | 1.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.4 | 1.3 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.4 | 4.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.4 | 3.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.4 | 4.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 2.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.4 | 5.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.4 | 1.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 | 1.2 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.4 | 6.0 | GO:0009650 | UV protection(GO:0009650) |
| 0.4 | 2.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 | 4.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.4 | 2.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.4 | 3.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.4 | 2.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 | 2.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.4 | 1.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.4 | 3.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.4 | 3.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.4 | 3.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 | 1.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.4 | 3.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.4 | 3.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 3.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.4 | 0.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 0.4 | 6.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.4 | 4.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 | 2.2 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.4 | 2.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.4 | 1.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.4 | 2.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.4 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.4 | 1.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.4 | 7.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 | 3.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.4 | 0.4 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.4 | 0.4 | GO:0072716 | response to actinomycin D(GO:0072716) |
| 0.4 | 1.8 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.4 | 1.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 1.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.3 | 1.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.3 | 1.4 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 0.7 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 | 1.3 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.3 | 2.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.3 | 3.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.3 | 1.7 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 | 3.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 4.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.3 | 1.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.3 | 9.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 16.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 | 1.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.3 | 2.8 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.3 | 3.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.3 | 0.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 6.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.3 | 49.4 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.3 | 2.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.3 | 1.5 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.3 | 1.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.3 | 2.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.3 | 1.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 12.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 1.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.3 | 6.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 | 2.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.3 | 4.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 5.9 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.3 | 0.8 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 2.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.3 | 2.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 | 1.1 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.3 | 1.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.3 | 1.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.3 | 5.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 14.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 | 1.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 1.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.3 | 11.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.3 | 2.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 0.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.3 | 1.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 | 0.8 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.3 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 1.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.3 | 0.8 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.3 | 0.8 | GO:0042245 | RNA repair(GO:0042245) |
| 0.3 | 2.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.3 | 2.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 | 2.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.3 | 3.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 2.7 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 | 3.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.2 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 1.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 | 3.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.2 | 3.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 2.9 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.2 | 1.4 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 | 3.3 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.2 | 3.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 1.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) seminal vesicle development(GO:0061107) |
| 0.2 | 3.5 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.2 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 6.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 1.2 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.2 | 4.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 1.2 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.2 | 3.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 | 4.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.2 | 0.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 3.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 0.4 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.2 | 1.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 5.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 3.5 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.2 | 2.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 3.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.2 | 3.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.2 | 2.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 2.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 1.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 4.6 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.2 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 1.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.2 | 3.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 1.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.2 | 3.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 1.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.2 | 1.0 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 2.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 3.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 1.0 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.2 | 1.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.2 | 1.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.2 | 6.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 0.9 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 | 2.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 1.1 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 | 1.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.2 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 1.6 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.2 | 1.0 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.2 | 2.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 1.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.2 | 5.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 5.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.2 | 0.8 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 2.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 2.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 2.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 1.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.2 | 3.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.2 | 2.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 8.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 2.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 1.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 1.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 | 0.9 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.2 | 2.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 2.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 3.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 0.9 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 1.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 1.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 2.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 1.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 3.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.6 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 | 1.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 4.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 1.4 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 1.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.1 | 2.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 10.7 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.1 | 4.9 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 1.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 | 1.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 1.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.5 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 | 4.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.1 | 3.8 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 1.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.1 | 0.2 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.1 | 0.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 2.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 1.3 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
| 0.1 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 0.4 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.1 | 0.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 | 0.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 0.5 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 6.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 1.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 2.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 | 2.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 3.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.1 | 1.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 | 1.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 12.9 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 4.9 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 1.9 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.9 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.1 | 0.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 3.9 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.4 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 1.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 1.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 2.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 0.5 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.8 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.1 | 0.4 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.1 | 1.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 1.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 3.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 2.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 1.0 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
| 0.1 | 0.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 1.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 4.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 0.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 1.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.6 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
| 0.1 | 1.8 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 2.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.5 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.1 | 0.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 3.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.3 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) |
| 0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 2.7 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 1.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 1.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.1 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 0.6 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.6 | GO:0060968 | regulation of gene silencing(GO:0060968) |
| 0.1 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 5.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.1 | 0.1 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 1.5 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.9 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 1.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 2.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 1.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 1.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.1 | 1.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.1 | 1.7 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.1 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.1 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 2.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 1.2 | GO:1904357 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.1 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 5.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 2.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 | 0.2 | GO:1990086 | neuroblast differentiation(GO:0014016) forebrain dorsal/ventral pattern formation(GO:0021798) lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 2.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.1 | 4.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.0 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.1 | 2.4 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
| 0.1 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 1.4 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 | 1.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.5 | GO:0035268 | protein mannosylation(GO:0035268) |
| 0.0 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 2.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 2.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.5 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.0 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.2 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.0 | 1.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.0 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 6.1 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.0 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 3.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.0 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 | 0.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 1.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 | 0.9 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.0 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.0 | 1.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.0 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 | 1.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.0 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.2 | GO:0045899 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) response to arachidonic acid(GO:1904550) |
| 0.0 | 0.3 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.0 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 | 2.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.5 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.0 | 0.3 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.2 | GO:0003279 | cardiac septum development(GO:0003279) |
| 0.0 | 2.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 0.4 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 | 0.5 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.0 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.3 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 | 4.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.0 | 0.1 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 | 0.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 1.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.5 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
| 0.0 | 0.3 | GO:0090102 | cochlea development(GO:0090102) |
| 0.0 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.0 | 0.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.1 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 0.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.0 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.0 | 0.4 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 0.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 1.9 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.0 | 0.2 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.0 | 0.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.0 | 0.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 | 0.8 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.0 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 | 0.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 | 1.1 | GO:1990748 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.0 | 0.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.0 | 1.3 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.7 | 35.0 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 6.0 | 24.0 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 4.7 | 41.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 4.6 | 13.9 | GO:0035101 | FACT complex(GO:0035101) |
| 3.6 | 65.4 | GO:0042555 | MCM complex(GO:0042555) |
| 3.6 | 14.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 3.4 | 26.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 3.1 | 9.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 3.1 | 39.7 | GO:0000796 | condensin complex(GO:0000796) |
| 3.0 | 3.0 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 2.4 | 7.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 2.4 | 7.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.4 | 33.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 2.4 | 28.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 2.3 | 13.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 2.3 | 9.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 2.3 | 13.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 2.3 | 6.8 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 2.2 | 6.5 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 2.0 | 6.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 2.0 | 11.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.9 | 7.7 | GO:0000811 | GINS complex(GO:0000811) |
| 1.7 | 17.1 | GO:0005638 | lamin filament(GO:0005638) |
| 1.6 | 4.9 | GO:0008623 | CHRAC(GO:0008623) |
| 1.4 | 13.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.3 | 10.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.3 | 6.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 1.3 | 2.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.3 | 8.8 | GO:0098536 | deuterosome(GO:0098536) |
| 1.2 | 4.9 | GO:0044301 | climbing fiber(GO:0044301) |
| 1.1 | 3.3 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 1.1 | 7.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.1 | 4.3 | GO:0031523 | Myb complex(GO:0031523) |
| 1.1 | 14.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 1.0 | 6.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.0 | 19.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 1.0 | 10.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 1.0 | 18.3 | GO:0045120 | pronucleus(GO:0045120) |
| 1.0 | 5.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.9 | 6.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.8 | 2.5 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.8 | 15.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.8 | 3.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.7 | 3.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.7 | 2.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.7 | 4.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.7 | 3.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
| 0.7 | 2.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.7 | 3.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.6 | 3.2 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.6 | 3.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.6 | 3.0 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.6 | 14.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.6 | 4.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.6 | 3.9 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.6 | 5.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.5 | 1.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.5 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.5 | 4.2 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.5 | 2.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.5 | 1.5 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.5 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.5 | 2.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.5 | 2.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.5 | 3.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.5 | 8.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.5 | 7.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.5 | 1.9 | GO:1990423 | Dsl1p complex(GO:0070939) RZZ complex(GO:1990423) |
| 0.5 | 3.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.5 | 4.8 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.5 | 1.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 6.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 16.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.4 | 4.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 2.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 1.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.4 | 6.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.4 | 2.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.4 | 1.6 | GO:0005712 | chiasma(GO:0005712) |
| 0.4 | 1.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.4 | 13.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.4 | 1.2 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.4 | 4.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 44.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.4 | 1.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 0.9 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 6.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.3 | 17.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.3 | 9.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.3 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.3 | 2.0 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 4.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.3 | 2.5 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.3 | 1.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.3 | 16.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
| 0.3 | 2.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.3 | 4.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 1.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.3 | 1.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 0.7 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 0.2 | 0.7 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 1.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.2 | 5.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 8.2 | GO:0000776 | kinetochore(GO:0000776) |
| 0.2 | 1.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 0.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 16.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 1.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 6.5 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 1.3 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 0.9 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
| 0.2 | 1.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.2 | 1.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.2 | 1.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
| 0.2 | 28.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.2 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 6.3 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 1.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 6.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 0.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.2 | 3.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 2.8 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.5 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 10.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 2.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 5.6 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 0.7 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 1.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 2.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 15.3 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.3 | GO:0075341 | host cell PML body(GO:0075341) |
| 0.1 | 2.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 1.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 9.4 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 10.0 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 12.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 8.5 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 2.4 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
| 0.1 | 5.4 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 11.1 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
| 0.1 | 0.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 2.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.3 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.1 | 1.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 2.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 1.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 2.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 16.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 2.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 2.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.1 | 2.8 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 3.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 2.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 4.8 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 7.9 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 5.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 2.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 3.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 2.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 20.5 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 8.7 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 2.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 2.0 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.0 | 3.9 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 1.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 0.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 3.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 5.7 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 3.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 16.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 3.6 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 4.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.0 | 6.3 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 1.7 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.5 | GO:0005938 | cell cortex(GO:0005938) |
| 0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 1.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 1.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 3.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.7 | 35.0 | GO:0032181 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 4.5 | 13.4 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 4.0 | 40.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 3.5 | 20.9 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 3.4 | 10.1 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 3.4 | 13.4 | GO:0003896 | DNA primase activity(GO:0003896) |
| 3.4 | 26.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 3.3 | 16.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 3.1 | 9.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 2.1 | 21.0 | GO:0043515 | kinetochore binding(GO:0043515) |
| 2.1 | 2.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 2.0 | 7.9 | GO:0043398 | HLH domain binding(GO:0043398) |
| 1.9 | 7.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 1.9 | 17.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 1.7 | 8.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 1.7 | 10.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.7 | 5.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 1.6 | 9.7 | GO:0051870 | methotrexate binding(GO:0051870) |
| 1.6 | 6.4 | GO:0016812 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 1.6 | 20.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 1.5 | 7.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 1.5 | 17.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.4 | 2.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 1.4 | 5.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 1.3 | 14.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 1.3 | 26.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.3 | 3.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.2 | 6.2 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 1.2 | 4.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.2 | 16.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 1.1 | 58.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 1.1 | 3.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 1.1 | 7.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.1 | 6.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.1 | 3.3 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.1 | 1.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 1.0 | 3.1 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 1.0 | 9.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 1.0 | 8.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.0 | 6.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.0 | 3.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.0 | 5.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.0 | 4.0 | GO:0004335 | galactokinase activity(GO:0004335) |
| 1.0 | 4.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 1.0 | 12.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 1.0 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 1.0 | 3.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.9 | 7.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.9 | 3.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.9 | 5.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.9 | 4.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.9 | 2.7 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.9 | 13.1 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.8 | 3.4 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.8 | 3.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.8 | 2.5 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.8 | 3.3 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.8 | 3.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.8 | 3.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.8 | 26.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.8 | 19.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.7 | 4.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.7 | 3.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.7 | 6.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.7 | 2.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.7 | 5.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.7 | 4.8 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.7 | 4.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.7 | 2.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.7 | 14.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.7 | 2.0 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.7 | 2.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.7 | 5.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.6 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.6 | 2.5 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.6 | 13.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.6 | 11.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.6 | 5.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.6 | 1.7 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.6 | 2.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.6 | 2.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.6 | 2.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.6 | 4.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.6 | 2.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.5 | 10.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 2.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.5 | 6.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.5 | 2.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.5 | 1.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.5 | 4.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.5 | 16.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.5 | 2.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.5 | 2.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.5 | 8.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.5 | 8.3 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.5 | 1.9 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.5 | 3.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.5 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.5 | 5.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.5 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 1.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.5 | 11.3 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
| 0.4 | 5.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.4 | 2.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 1.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.4 | 0.9 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 2.2 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.4 | 33.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.4 | 2.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 1.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.4 | 1.2 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.4 | 2.0 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.4 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 3.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.4 | 1.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.4 | 6.7 | GO:0016594 | glycine binding(GO:0016594) |
| 0.4 | 1.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.4 | 2.7 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.4 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.4 | 0.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.4 | 11.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.4 | 2.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.4 | 2.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.4 | 4.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 1.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.4 | 2.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 3.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.4 | 3.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 1.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.4 | 1.1 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.4 | 5.0 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 9.2 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.4 | 1.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.3 | 2.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.3 | 6.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 3.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 10.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 1.0 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 0.7 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.3 | 5.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.3 | 2.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 1.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.3 | 1.6 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.3 | 0.9 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.3 | 4.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 1.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.3 | 5.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.3 | 1.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.3 | 2.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.3 | 8.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.3 | 1.1 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.3 | 2.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.3 | 0.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.3 | 1.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 3.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 0.8 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.3 | 1.0 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.3 | 2.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 0.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.2 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.7 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.2 | 2.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 1.7 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
| 0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 2.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 5.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.2 | 8.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 2.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 0.9 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 2.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 20.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.2 | 7.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 0.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 3.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.2 | 2.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 1.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 1.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.2 | 0.4 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.2 | 5.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 30.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.2 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 1.0 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 0.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.2 | 0.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.2 | 3.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 8.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 3.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.2 | 30.9 | GO:0042393 | histone binding(GO:0042393) |
| 0.2 | 1.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 2.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 1.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.2 | 7.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 9.5 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.2 | 2.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 3.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 11.4 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 1.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 1.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 0.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 1.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 1.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.2 | 2.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 3.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 19.8 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 2.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 2.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 1.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 3.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 22.7 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 3.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 1.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 0.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 6.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 2.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 4.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 2.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.5 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 4.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 2.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 7.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.1 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 3.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 3.1 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.1 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 4.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 5.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 9.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 5.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 2.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 1.6 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 3.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.2 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 2.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 3.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.9 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 0.6 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 1.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 1.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.6 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 2.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 2.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.6 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 5.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.1 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 2.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 1.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.1 | 1.8 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 8.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.1 | 2.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.4 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 2.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 2.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 3.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.0 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 2.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 6.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 1.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.6 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 2.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.0 | 10.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 1.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.0 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 1.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.0 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.0 | 1.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 2.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 1.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.0 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 4.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 1.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.0 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.0 | 1.9 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.0 | 1.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 2.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 1.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 1.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.1 | GO:0009383 | C-methyltransferase activity(GO:0008169) rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.0 | 3.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.0 | 2.9 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
| 0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.6 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 0.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 139.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 1.2 | 1.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 1.1 | 13.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.1 | 54.3 | PID ATR PATHWAY | ATR signaling pathway |
| 0.9 | 0.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 35.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.4 | 5.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 5.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 37.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.3 | 17.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 13.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 8.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 12.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 3.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 2.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 22.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 4.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 14.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 5.4 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.3 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 5.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 6.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 10.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 8.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 4.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 8.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 7.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 4.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 16.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 6.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 3.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 2.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 2.7 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 2.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 6.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 6.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 3.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 2.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 7.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 2.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 2.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 4.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 2.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 2.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 76.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 3.6 | 68.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 1.8 | 20.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 1.8 | 51.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.6 | 56.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 1.5 | 40.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 1.2 | 19.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 1.0 | 36.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.9 | 17.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.8 | 3.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.7 | 15.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.7 | 51.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.7 | 12.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.6 | 7.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.6 | 10.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.6 | 18.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.6 | 9.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.6 | 5.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.6 | 22.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 15.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.5 | 24.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.4 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.4 | 5.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.4 | 6.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 4.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.4 | 6.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 42.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.3 | 7.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.3 | 2.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.3 | 12.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 9.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 7.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.3 | 13.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.3 | 7.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 4.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 13.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.2 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 7.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 3.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 15.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 5.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 2.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 3.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.2 | 3.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.2 | 1.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 3.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.2 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 5.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.2 | 3.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 2.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 5.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 9.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 2.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 3.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 3.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 5.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 4.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 1.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 8.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 0.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 2.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 2.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 4.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.1 | 3.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 2.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 3.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 2.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 6.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.6 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 0.1 | 7.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 4.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 1.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 4.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 3.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.1 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 1.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 3.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 17.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 2.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 3.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.0 | 3.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 2.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 1.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 1.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 1.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |